We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

OBT Appoints Dr Esteban Pombo-Villar as Chief Operations Officer

News   May 07, 2012

 
OBT Appoints Dr Esteban Pombo-Villar as Chief Operations Officer
 
 
 

RELATED ARTICLES

New Study of HIV Vaccine Shows Promising Results Across Strains

News

Using the same RV 144 HIV vaccine employed in Thailand, a new study has evaluated whether the vaccine-induced immune responses to RV 144 are similar in a South African cohort.

READ MORE

Discontinuing Oral Immunotherapy for Peanut Allergy Reduces Its Protective Effects

News

A study has followed participants after oral immunotherapy (OIT) for peanut allergy have found that discontinuing OIT or continuing OIT at a reduced dose led to a decline in its protective effects.

READ MORE

B Cells May Be More Important in Immunotherapy Than Previously Thought

News

Researchers have found evidence that B cells might play an important role in immunotherapy for melanoma. Currently, immunotherapy is primarily focused on T cells, but the results suggest that B cells could also provide an interesting research avenue.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE